{
"NDC": {
"NDCCode": "80674-210-10",
"PackageDescription": "10 VIAL, SINGLE-USE in 1 CARTON (80674-210-10) / 10 mL in 1 VIAL, SINGLE-USE (80674-210-01) ",
"NDC11Code": "80674-0210-10",
"ProductNDC": "80674-210",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Sesquient",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Fosphenytoin Sodium",
"DosageFormName": "INJECTION, SOLUTION",
"RouteName": "INTRAVENOUS",
"StartMarketingDate": "20210601",
"EndMarketingDate": "20231231",
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA210864",
"LabelerName": "Sedor Pharmaceuticals, LLC",
"SubstanceName": "FOSPHENYTOIN SODIUM",
"StrengthNumber": "500",
"StrengthUnit": "mg/10mL",
"Pharm_Classes": "Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2024-01-02",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": null,
"StartMarketingDatePackage": "20210601",
"EndMarketingDatePackage": "20231231",
"SamplePackage": "N"
}
}